Skip to search formSkip to main contentSkip to account menu

Naproxen 375 MG Delayed Release Oral Tablet [Naprosyn]

Known as: EC-Naprosyn 375 MG Delayed Release Oral Tablet, NAPROXEN 375 mg ORAL TABLET, DELAYED RELEASE [EC-Naprosyn], Naprosyn 375 MG Delayed Release Oral Tablet 
National Institutes of Health

Related topics

Related topics

11 relations
Croscarmellose SodiumDelayed Release Oral TabletMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)Magnesium stearate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
The aim of this work was to evaluate the effect of two chemically different edge activators, i.e., Tween® 80 and sodium… 
2017
2017
Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis
Background Radiofrequency endometrial ablation (REA) is currently a second line treatment in women with heavy menstrual bleeding… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)